A recent study explores the experiences of marketing authorization holders in utilizing real-world data and evidence for drug development and regulatory submissions in the EU. This research highlights the growing importance of real-world evidence in shaping regulatory decisions.
through the lens of marketing authorization holders experience in use of real world data and real world evidence in drug development and regulatory submissions in eu
Original title: “Through the lens of marketing authorization holders: experience in use of real-world data and real-world evidence in drug development and regulatory submissions in EU.”